Ski acts as therapeutic target of qingyihuaji formula in the treatment of SW1990 pancreatic cancer.
Wang
Peng
P
Shanghai Medical College, Fudan University, Shanghai, China.
Chen
Zhen
Z
Meng
Zhi-Qiang
ZQ
Luo
Jian-Min
JM
Lin
Jun-Hua
JH
Zhou
Zhen-Hua
ZH
Chen
Hao
H
Wang
Kun
K
Shen
Ye-Hua
YH
Liu
Lu-Ming
LM
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000494:pharmacology; D002277:Carcinoma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology; D016503:Drug Delivery Systems; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology; D023041:Xenograft Model Antitumor Assays
D000972:Antineoplastic Agents, Phytogenic; D004268:DNA-Binding Proteins; D004365:Drugs, Chinese Herbal; D011518:Proto-Oncogene Proteins; C550234:Qingyihuaji; C060614:SKI protein, human